Exploring the future of research in the Tp53 field

Targeting the P53 Protein for Cancer Therapies: The Translational Impact of P53 Research

(2022) Arnold J. Levine   CANCER RESEARCH

p53 in ferroptosis regulation: the new weapon for the old guardian

(2022) Yanqing Liu et al.   CELL DEATH AND DIFFERENTIATION

Should mutant TP53 be targeted for cancer therapy?

(2022) Zilu Wang et al.   CELL DEATH AND DIFFERENTIATION

The genotypes and phenotypes of missense mutations in the proline domain of the p53 protein

(2022) David Hoyos et al.   CELL DEATH AND DIFFERENTIATION

The TP53 Database: transition from the International Agency for Research on Cancer to the US National Cancer Institute

(2022) Kelvin César de Andrade et al.   CELL DEATH AND DIFFERENTIATION

Mutant p53: it’s not all one and the same

(2022) Margaret C. Kennedy et al.   CELL DEATH AND DIFFERENTIATION

Structural diversity of p63 and p73 isoforms

(2022) Christian Osterburg et al.   CELL DEATH AND DIFFERENTIATION

Cell cycle regulation: p53-p21-RB signaling

(2022) Kurt Engeland   CELL DEATH AND DIFFERENTIATION

p53 at the crossroad of DNA replication and ribosome biogenesis stress pathways

(2022) Mikael S. Lindström et al.   CELL DEATH AND DIFFERENTIATION

Of the many cellular responses activated by TP53, which ones are critical for tumour suppression?

(2022) Annabella F. Thomas et al.   CELL DEATH AND DIFFERENTIATION

Spontaneous and inherited TP53 genetic alterations

(2021) Arnold J. Levine   ONCOGENE

Geometric network analysis provides prognostic information in patients with high grade serous carcinoma of the ovary treated with immune checkpoint inhibitors

(2021) Rena Elkin et al.   npj Genomic Medicine

p53, cancer and the immune response

(2020) Julianna Blagih et al.   JOURNAL OF CELL SCIENCE

Higher-than-expected population prevalence of potentially pathogenic germline TP53 variants in individuals unselected for cancer history

(2017) Kelvin César de Andrade et al.   HUMAN MUTATION